Celanese has unveiled VitalDose, an excipient for controlled-release drugs. The ingredients allow drugmakers to customize API release properties.
VitalDose is intended for transdermal, subcutaneous implant, and mucosal insert dosage forms, the company says. The specialty materials maker is targeting the opportunity it sees in new routes of administration for existing drugs as a means of thwarting generics competition. Enhanced bioavailability of poorly soluble drugs is another application.
The new excipients are based on ethylene vinyl acetate polymers.
- here's the Celanese announcement